SCHEMBL9923859

SCHEMBL9923859

CCOC(=O)N[C@H]1CC[C@H](N/C(=N\C(=O)c2ccc(F)c(F)c2)NCc2cc(F)ccc2F)CC1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.41
ROCK2 O75116 1/20 0.38
ROCK1 Q13464 1/20 0.38
MCHR1 Q99705 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HTR7 P34969 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
CYP2C9 P11712 2/20 0.36
MAPK14 Q16539 2/20 0.36
SIGMAR1 Q99720 1/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
TSHR P16473 1/20 0.35
CYP11B2 P19099 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9923858 0.94 ALDH1A1 (0.41) CHRM1MCHR1SMN1; SMN2LMNAHTT
SCHEMBL9924065 0.91 P2RX7 (0.42)
SCHEMBL9924274 0.91 CHRM1 (0.41) CHRM1ROCK2ROCK1MCHR1CYP2C9
SCHEMBL9924066 0.88 CHRM1 (0.41) CHRM1MCHR1SMN1; SMN2LMNAHTT
SCHEMBL9923856 0.88 CHRM1 (0.42) CHRM1ROCK2ROCK1MCHR1SMN1; SMN2
SCHEMBL9923860 0.88 P2RX7 (0.40) CHRM1MCHR1SMN1; SMN2LMNACYP2C9
SCHEMBL9923857 0.88 LMNA (0.40) CHRM1ROCK2ROCK1SMN1; SMN2LMNA
SCHEMBL9924064 0.88 CHRM1 (0.40) CHRM1ROCK2ROCK1MCHR1SMN1; SMN2
SCHEMBL9924156 0.87 CHRM1 (0.45) CHRM1MCHR1CYP2C9MAPK14ALDH1A1
SCHEMBL9924270 0.87 HPGD (0.40) CHRM1MCHR1SMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed